The Reversal of Weight Loss: Zepbound Patients Regain Pounds After Stopping Drug

Patients who took Eli Lilly's weight loss drug Zepbound regained around half the weight they lost after stopping the treatment for a year, according to a study funded by Eli Lilly. The data suggests that continued therapy is necessary to maintain significant weight loss. The study showed that patients who continued Zepbound were able to maintain at least 80% of their weight loss, while those who stopped the drug regained about 14.8% of their weight. The findings highlight the ongoing treatment required for obesity and raise concerns about the high costs involved with long-term coverage of weight loss drugs.